Abivax (ABVX) Cash from Operations (2024 - 2026)
Abivax (ABVX) posted quarterly Cash from Operations of 59144899.5 for Q1 2026, down 68.96% year-over-year from 190563599.23 in Q1 2025, and down 119.02% quarter-over-quarter from 27004645.5 in Q4 2025.
Abivax (ABVX) Cash from Operations (2024 - 2026) Analysis & Trends
Abivax's Cash from Operations history runs 3 years deep, the most recent figure standing at 59144899.5 for Q1 2026.
- In Q1 2026, Cash from Operations fell 68.96% year-over-year to 59144899.5; the TTM figure through Mar 2026 stood at 207222835.07 (down 26.35% YoY), while the FY2025 annual figure was 187527410.22, down 13.88% from the prior year.
- Cash from Operations for Q1 2026 stood at 59144899.5, down from 27004645.5 in the prior quarter.
- The five-year high for Cash from Operations was 27004645.5 in Q4 2025, with the low at 83333754.08 in Q3 2025.
- The 3-year median for Cash from Operations is 37755416.85 (2024), against an average of 45442415.37.
- Peak annual rise in Cash from Operations reached 30.5% in 2025, while the deepest fall reached 114.46% in 2025.
- Abivax's Cash from Operations stood at 35842826.91 in 2024, then increased by 24.66% to 27004645.5 in 2025, then sank by 119.02% to 59144899.5 in 2026.
- Business Quant data shows ABVX's Cash from Operations at 59144899.5 in Q1 2026, 27004645.5 in Q4 2025, and 83333754.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | -59.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.14 Mn |
| Mar 31, 2026 | -59.14 Mn |
| Dec 31, 2025 | -27.00 Mn |
| Dec 31, 2025 | -27.00 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Sep 30, 2025 | -83.33 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Jun 30, 2025 | -37.74 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Mar 31, 2025 | -35.00 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Dec 31, 2024 | -35.84 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Sep 30, 2024 | -38.86 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Jun 30, 2024 | -54.30 Mn |
| Mar 31, 2024 | -37.76 Mn |
| Mar 31, 2024 | -37.76 Mn |